Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersInternal Medicine Physician in HI
NPI: 1740522473HQ Phone
Get M.D. Scott's Phone Numberphone_androidMobile
Get M.D. Scott's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardHI State Medical License
Authors: Smolewski, Piotr, Robak, Pawel, Cebula-Obrzut, Barbara, Misiewicz, Małgorzata, Mędra, Aleksandra, Majchrzak, Agata, Witkowska, Magdalena, Stromatt, Scott, Robak, Tadeusz
Journal: Eur J Cancer
Publication Date: 2014-08-18
Phase 1b study of otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR™ therapeutic protein, in combination with rituximab and bendamustine in relapsed indolent lymphoma patients.
Authors: Ajay Gopal, Damian Green, Stefano Tarantolo, Tatyana Feldman, Andre Goy
Publication Date: 2014-04-16
Otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR(™) therapeutic protein, for relapsed or refractory NHL patients.
Authors: Ian Flinn, Ajay Gopal, John Pagel, Farrukh Awan, Mark Lanasa
Publication Date: 2014-04-02